A microelectronic device is formed by forming a platinum-containing layer on a substrate of the microelectronic device. A cap layer is formed on the platinum-containing layer so that an interface between the cap layer and the platinum-containing layer is free of platinum oxide. The cap layer is etchable in an etch solution which also etches the platinum-containing layer. The cap layer may be formed on the platinum-containing layer before platinum oxide forms on the platinum-containing layer. Alternatively, platinum oxide on the platinum-containing layer may be removed before forming the cap layer. The platinum-containing layer may be used to form platinum silicide. The platinum-containing layer may be patterned by forming a hard mask or masking platinum oxide on a portion of the top surface of the platinum-containing layer to block the wet etchant.

A cathode configured to use oxygen as a cathode active material includes: a porous film including a metal oxide, where a porosity of the porous film is about 50 volume percent to about 95 volume percent, based on a total volume of the porous film, and an amount of an organic component in the porous film is 0 to about 2 weight percent, based on a total weight of the porous film.

Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Provided is a method of preparing palladium hydride nanoparticles having a hcp crystal structure.

According to an embodiment of the present invention, the method includes: (a) preparing a liquid cell containing a palladium precursor solution; (b) applying electron beams to the palladium precursor solution contained in the liquid cell; and (c) generating palladium hydride nanoparticles having the hcp crystal structure in the palladium precursor solution.

Provided is a method of preparing palladium hydride nanoparticles having a hcp crystal structure.

According to an embodiment of the present invention, the method includes: (a) preparing a liquid cell containing a palladium precursor solution; (b) applying electron beams to the palladium precursor solution contained in the liquid cell; and (c) generating palladium hydride nanoparticles having the hcp crystal structure in the palladium precursor solution.

A process for efficiently and economically recovering palladium from a colloidal suspension of tin and palladium involves the use of centrifugation to obtain a sediment enriched in tin and a centrifugate enriched in palladium. An aggregating agent is employed to enhance separation during centrifugation, and ion exchange may be employed to recover palladium from the centrifugate.

A method for making iridium oxide nanoparticles includes dissolving an iridium salt to obtain a salt-containing solution, mixing a complexing agent with the salt-containing solution to obtain a blend solution, and adding an oxidating agent to the blend solution to obtain a product mixture. A molar ratio of a complexing compound of the complexing agent to the iridium salt is controlled in a predetermined range so as to permit the product mixture to include iridium oxide nanoparticles.

Detection reagent is formed by reacting a catalyst and xanthydrol. The catalyst includes an active component loaded on a support, wherein the active component includes Pt, Ru, Rh, or a combination thereof, and the support includes carbon material, silica, alumina, or calcium carbonate. The detection reagent can be used to detect the primary amide compound.

The disclosure relates to a two-dimensional (2D) bismuth nanocomposite, and a preparation method and use thereof, and belongs to the field of nanobiotechnology. The 2D bismuth nanocomposite of the disclosure is an ultra-thin bismuth nanosheet that is loaded with platinum nanoparticles and modified with indocyanine green (ICG) and surface targeting polypeptide Ang-2. The 2D bismuth nanocomposite Bi@Pt/ICG-Ang2 of the disclosure can not only realize the targeted photothermal and photodynamic combination therapy for tumors, but also realize the dual-mode imaging combining CT and fluorescence imaging.